Reliq Health Technologies, Inc. Announces 30 New Skilled Nursing Facility Clients in FL and a New Contract with a Large Clinic in TX
Reliq Health Technologies Inc. (OTC:RQHTF) has expanded its healthcare services by adding 30 new Skilled Nursing Facility (SNF) clients and securing a contract with a large allergy and respirology clinic in Texas. This expansion is expected to increase patient capacity by over 41,000 annually, with revenue anticipated at $65 per patient per month, maintaining a gross margin of 75%. Reliq's iUGO Care platform continues to support remote healthcare management, positioning the company for significant growth in the healthcare sector.
- Added 30 new SNF clients, expected to add over 36,000 patients per year.
- Secured a contract with a large allergy and respirology clinic, adding 5,000 patients.
- Projected average revenue of $65 per patient per month with a 75% gross margin.
- None.
HAMILTON, Ontario, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it has added 30 new Skilled Nursing Facility (SNF) clients to a previously disclosed contract with a large healthcare network in Florida. The Company has also signed a new contract with a large allergy and respirology clinic in Texas. The new SNF clients are expected to add over 3,000 new patients per month or 36,000 new patients per year to Reliq’s iUGO Care platform. The allergy and respirology clinic is expected to add 5,000 patients to the platform by the end of 2023.
“We are excited to continue to expand our presence in the Skilled Nursing space, and to be adding a new client in the allergy and respirology field,” said Dr. Lisa Crossley, CEO at Reliq Health Technologies, Inc. “The allergy and respirology clinic will be using the iUGO Care Remote Therapeutic Monitoring (RTM) and Principal Care Management (PCM) modules as well as other core iUGO Care modules. The SNFs will be using our Transitional Care Management (TCM), Remote Patient Monitoring (RPM), Chronic Care Management (CCM) and Behavioural Health Integration (BHI) modules. We have already started onboarding with the allergy and respirology clinic and expect to start onboarding with the new SNFs next month. We expect to add over 36,000 SNF patients and over 5,000 allergy and respirology patients to our iUGO Care platform by the end of this year through these contracts, at an average revenue of
Reliq Health
Reliq Health Technologies is a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the Frankfurt Stock Exchange under the WKN:A2AJTB.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information please contact:
Company Contact
Investor Relations at ir@reliqhealth.com
US Investor Relations Contact
Investor Relations
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
646-829-9701
shamsian@lythampartners.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
FAQ
What recent expansion has Reliq Health Technologies made regarding its client base?
How many new patients are expected from the new contracts secured by Reliq Health?
What is the expected revenue per patient for Reliq Health Technologies?
What gross margin is projected by Reliq Health Technologies for its new patient additions?
What healthcare technology platform does Reliq Health use?
